An Observational Study of Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus (HCV) Infection in Austria
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This noninterventional, open-label study will observe the safety and tolerability of
peginterferon alfa-2a in combination with ribavirin among Austrian participants treated for
HCV infection according to routine practice.